Inflammatory Bowel Disease

Discussing the latest advances in Crohn’s disease and ulcerative colitis

Items Tagged ‘Entyvio’

May 3, 2016

Vedolizumab Safe for Inflammatory Bowel Disease

By Kanaaz Pereira kanaazpe

Vedolizumab (proposed trade name Entyvio), was developed as a treatment for patients with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD), who have failed at least one conventional therapy, including tumor necrosis factor (TNF) antagonists. Dr. Edward Loftus, M.D., reviews a recent study published in the journal Gut, in which researchers reported on […]

View full entry

Tags: Crohn's disease, Edward Loftus, Entyvio, GUT, IBD, monoclonal antibody, ulcerative colitis, Vedolizumab

July 1, 2014

FDA Approves Entyvio to Treat Ulcerative Colitis and Crohn’s Disease

By Margaret Shepard, Communications Specialist Margaret_Marie

Edward Loftus Jr, M. D., discusses the recent FDA approval of Entyvio to treat ulcerative colitis and Crohn’s disease.   Entyvio represents a relatively new class of medications for inflammatory bowel disease (IBD). It’s a biologic drug containing an antibody against the molecule alpha 4 beta 7. This is a targeted biologic for blood vessels […]

View full entry

Tags: Crohn's disease, Edward Loftus, Entyvio, FDA, ulcerative colitis

Contact Us · Privacy Policy